John Valliant

Insider Reports History

Location
Hamilton, Ontario, Canada
Signature
/s/ Maria Stahl as Attorney-in-Fact for John Valliant
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Valliant:

Company Role Class Num Shares Value Price $ Report Date Ownership
Fusion Pharmaceuticals Inc. Chief Executive Officer, Director Restricted Stock Units 0 $390,166 $2.03 04 Jun 2024 Direct
Fusion Pharmaceuticals Inc. Chief Executive Officer, Director Common Stock 0 04 Jun 2024 Direct
Fusion Pharmaceuticals Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 04 Jun 2024 Direct

Insider Reports Filed by John Valliant

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024068905-valliant-john-2024-06-04 Fusion Pharmaceuticals Inc. 04 Jun 2024 12 $0 4 Chief Executive Officer, Director 04 Jun 2024, 17:31
/report/000095017024002291-valliant-john-2024-01-04 Fusion Pharmaceuticals Inc. 04 Jan 2024 2 $0 4 Chief Executive Officer, Director 05 Jan 2024, 08:41
/report/000120919123002499-valliant-john-2023-01-05 Fusion Pharmaceuticals Inc. 05 Jan 2023 1 $0 4 Chief Executive Officer, Director 09 Jan 2023, 05:46
/report/000120919122025783-valliant-john-2022-04-25 Fusion Pharmaceuticals Inc. 25 Apr 2022 3 -$52,511 4 Chief Executive Officer, Director 27 Apr 2022, 16:34
/report/000120919122025469-valliant-john-2022-04-20 Fusion Pharmaceuticals Inc. 20 Apr 2022 2 -$7,751 4 Chief Executive Officer, Director 22 Apr 2022, 20:04
/report/000120919122024330-valliant-john-2022-04-11 Fusion Pharmaceuticals Inc. 11 Apr 2022 3 -$225,654 4 Chief Executive Officer, Director 13 Apr 2022, 18:10
/report/000120919122023861-valliant-john-2022-04-06 Fusion Pharmaceuticals Inc. 06 Apr 2022 3 -$16,457 4 Chief Executive Officer, Director 08 Apr 2022, 16:21
/report/000120919122023124-valliant-john-2022-04-01 Fusion Pharmaceuticals Inc. 01 Apr 2022 3 -$29,324 4 Chief Executive Officer, Director 05 Apr 2022, 17:01
/report/000120919122022034-valliant-john-2022-03-30 Fusion Pharmaceuticals Inc. 30 Mar 2022 1 -$2,256 4 Chief Executive Officer, Director 01 Apr 2022, 17:36
/report/000120919122021487-valliant-john-2022-03-25 Fusion Pharmaceuticals Inc. 25 Mar 2022 3 -$77,694 4 Chief Executive Officer, Director 29 Mar 2022, 16:29
/report/000120919122020948-valliant-john-2022-03-22 Fusion Pharmaceuticals Inc. 22 Mar 2022 3 -$36,092 4 Chief Executive Officer, Director 24 Mar 2022, 17:32
/report/000120919122020316-valliant-john-2022-03-17 Fusion Pharmaceuticals Inc. 17 Mar 2022 3 -$27,126 4 Chief Executive Officer, Director 21 Mar 2022, 17:47
/report/000120919122019224-valliant-john-2022-03-14 Fusion Pharmaceuticals Inc. 14 Mar 2022 3 -$10,459 4 Chief Executive Officer, Director 16 Mar 2022, 16:29
/report/000120919122018455-valliant-john-2022-03-09 Fusion Pharmaceuticals Inc. 09 Mar 2022 3 -$19,832 4 Chief Executive Officer, Director 14 Mar 2022, 16:18
/report/000120919122017150-valliant-john-2022-03-04 Fusion Pharmaceuticals Inc. 04 Mar 2022 3 -$103,945 4 Chief Executive Officer, Director 08 Mar 2022, 15:59
/report/000120919122015555-valliant-john-2022-03-01 Fusion Pharmaceuticals Inc. 01 Mar 2022 3 -$205,201 4 Chief Executive Officer, Director 03 Mar 2022, 15:53
/report/000120919122013791-valliant-john-2022-02-24 Fusion Pharmaceuticals Inc. 24 Feb 2022 3 -$103,176 4 Chief Executive Officer, Director 28 Feb 2022, 18:13
/report/000120919122012344-valliant-john-2022-02-18 Fusion Pharmaceuticals Inc. 18 Feb 2022 3 -$298,434 4 Chief Executive Officer, Director 23 Feb 2022, 16:58
/report/000120919122010918-valliant-john-2022-02-15 Fusion Pharmaceuticals Inc. 15 Feb 2022 3 -$383,808 4 Chief Executive Officer, Director 17 Feb 2022, 16:39
/report/000120919122007056-valliant-john-2022-02-01 Fusion Pharmaceuticals Inc. 01 Feb 2022 1 $0 4 Chief Executive Officer, Director 03 Feb 2022, 18:40